To investigate the efficacy of intravitreal injection of recombinant tissue plasminogen activator (rt-PA), ranibizumab, and gas without vitrectomy for submacular hemorrhage.


Read full article on AAO Journal


Powered by Preisvergleich


WVAEPS Members

Member Login